Guomin Wu

Dr. Guomin Wu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Bioactive Materials
Verified
Journal Article
Open access
KCKai Chen
Kai Chen
FWFang Wang
Fang Wang
XSXiumei Sun
Xiumei Sun
WGWenwei Ge
Wenwei Ge
MZMingjun Zhang
Mingjun Zhang
GWGuomin Wu
Guomin Wu
Clinically, infectious bone defects represent a significant threat, leading to osteonecrosis, severely compromising patient prognosis, and prolonging hospital stays. Thus, there is an urgent need to develop a bone graft substitute that combines broad-spectrum antibacterial efficacy and bone-inductive properties, providing an effective treatment option for infectious bone defects. In this study, the precision of digital light processing (DLP) 3D printing technology was utilized to construct a scaffold, incorporating zinc oxide nanoparticles (ZnO-NPs) modified barium titanate (BT) with hydroxyapatite (HA), resulting in a piezoelectric ceramic scaffold designed for the repair of infected bone defects. The results indicated that the addition of ZnO-NPs significantly improved the piezoelectric properties of BT, facilitating a higher HA content within the ceramic scaffold system, which is essential for bone regeneration. In vitro antibacterial assessments highlighted the scaffold's potent antibacterial capabilities. Moreover, combining the synergistic effects of low-intensity pulsed ultrasound (LIPUS) and piezoelectricity, results demonstrated that the scaffold promoted notable osteogenic and angiogenic potential, enhancing bone growth and repair. Furthermore, transcriptomics analysis results suggested that the early growth response-1 (EGR1) gene might be crucial in this process. This study introduces a novel method for constructing piezoelectric ceramic scaffolds exhibiting outstanding osteogenic, angiogenic, and antibacterial properties under the combined influence of LIPUS, offering a promising treatment strategy for infectious bone defects.

19 December 2023 in Ceramics International
Verified
Journal Article
Closed access
KCKai Chen
Kai Chen
YWYingtong Wang
Yingtong Wang
CWChen Wu
Chen Wu
YDYao Du
Yao Du
HTHaoyu Tang
Haoyu Tang
GWGuomin Wu
Guomin Wu

28 February 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SZShikang Zheng
Shikang Zheng
XSXiumei Sun
Xiumei Sun
KCKai Chen
Kai Chen
MZMingjun Zhang
Mingjun Zhang
CZChentong Zou
Chentong Zou
GWGuomin Wu
Guomin Wu

28 November 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
CZChentong Zou
Chentong Zou
KCKai Chen
Kai Chen
SZShikang Zheng
Shikang Zheng
MZMingjun Zhang
Mingjun Zhang
YLYuyan Liu
Yuyan Liu
GWGuomin Wu
Guomin Wu

11 May 2024 in Journal of Dentistry
Verified
Journal Article
Closed access
SDShiying Dong
Shiying Dong
MPMengdong Peng
Mengdong Peng
GWGuomin Wu
Guomin Wu
CYChenmin Yao
Chenmin Yao
CHCui Huang
Cui Huang
SLShanshan Liang
Shanshan Liang

14 September 2022 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
KCKai Chen
Kai Chen
XSXiumei Sun
Xiumei Sun
YLYuhui Lin
Yuhui Lin
GWGuomin Wu
Guomin Wu
Midface hypoplasia sometimes appears in patients with skeletal class III malocclusion in the Asian population, often requires additional surgical treatments. The technical note is intended to introduce a modified Le Fort I arc osteotomy combined with autologous bone grafts harvested from proximal segments after bilateral sagittal split ramus osteotomy to improve the profile for skeletal class III malocclusion patients with midface hypoplasia. The benefit of the modified technology is that the size and position of the arc can be adjusted according to the severity of the deformity to suit different patients. In addition, the application of autologous bone grafts increased the extra height of osteotomy line and enhanced the surgical effect, and maintained bone consolidation. More importantly, the osteotomy line of the modified Le Fort I arc osteotomy can be easily designed and this modification will not cause additional injuries. Therefore, we believe that for skeletal class III malocclusion patients with midface hypoplasia in Asia modified Le Fort I arc osteotomy combined with autologous bone grafts will be an efficient surgical method to improve midface hypoplasia.